TLX Telix Pharmaceuticals Limited American Depositary Shares Pharmaceutical Preparations Best Pharmaceutical Stocks 2026 →

Telix Pharmaceuticals (TLX) Stock: Buy, Sell, or Hold?

$9.45
-0.44 (-4.45%) ▼
5d: +4.65% 30d: -16.3% 90d: -21.05%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (91%)
Quality Score
56/100
Position
SLIGHTLY LOW
30-Day Fair Range
$9.25 – $10.88
Position: SLIGHTLY LOW
Forward P/E & Valuation
-248.7x CHEAP
vs 35.2x historical avg
Wall Street Target
$20.24
+114.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$8.98 / $9.96
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: TLX shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.

Get Alerted When TLX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: TLX is currently trading at $9.45, which is considered slightly low relative to its 30-day fair value range of $9.25 to $10.88. From a valuation perspective, the stock is trading at a discount (Forward PE: -248.7) compared to its historical average (35.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, TLX is in a strong downtrend. Immediate support is located at $8.98, while resistance sits at $9.96. Short-term momentum is weak, with the stock down 4.4% recently.

Market Sentiment: TLX scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $20.24 (+114.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $9.25 - $10.88
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 90.5%

Trading Range & Key Levels

30-Day Trading Range $9.25 - $10.88
Current vs Trading Range SLIGHTLY LOW
Support Level $8.98
Resistance Level $9.96
Current Trend Strong Downtrend
Technical data as of Nov 10, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (66/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.4%)
  • BULLISH: Trading 114.2% below Wall St target ($20.24)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • BULLISH: Bottoming setup score 66/100 — corrected, stabilizing, and turning up

Fundamental Context

Forward P/E (Next Year Est.) -248.68
Wall Street Target $20.24 (+114.2%)
Revenue Growth (YoY) 22.3%
Profit Margin 3.8%
PE vs Historical -248.7 vs 35.2 CHEAP
Share TLX Analysis

Share this live TLX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (TLX)

Bearish 1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Mar 12, 2026
Daily AI digest
AI Retail Discussion Summary: Reddit & WallStreetBets discussions on TLX are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:28 AM ET
Data refreshes hourly during market hours. Next update: 10:28 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for TLX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
WVE
Wave Life Sciences Ltd
STRONG BUY
21 analysts
$17 43 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
20 analysts
$36 37 SELL
SRRK
Scholar Rock Holding Corp
STRONG BUY
18 analysts
$70 39 SELL
ARWR
Arrowhead Pharmaceutical…
STRONG BUY
15 analysts
$108 47 HOLD
MIRM
Mirum Pharmaceuticals Inc
STRONG BUY
14 analysts
$155 45 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive TLX Research Pages
TLX Technical Chart TLX Price Prediction TLX Intrinsic Value DCF TLX Earnings Date TLX Investment Advisor TLX Fair Price Analyzer TLX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals